Skip to main content

Advertisement

SpringerLink
Log in

Outcome of Locally Recurrent and Metastatic Angiosarcoma

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Angiosarcoma (AS) is a rare soft tissue sarcoma with an enhanced propensity for local and systemic failure. The outcome of locally recurrent and metastatic AS treated at a single institution was evaluated.

Methods

Medical records of AS patients treated for local recurrence and distant metastasis (1993–2008) were retrospectively reviewed. Univariable and multivariable analyses were performed to identify prognosticators.

Results

Forty-four patients were treated for locally recurrent AS; the majority (59%) were ≤5 cm; the most common sites were skin (48%) and breast (32%). Thirty-two patients (73%) had surgery; 73% received chemotherapy; radiation was delivered to 41%. Median disease-specific survival (DSS) was 50 months [95% confidence interval (CI): 25.7–73.5 months]. Multivariable analysis identified size >5 cm as the only independent adverse prognosticator of recurrent AS-specific survival [hazard ratio (HR): 3.26, P = 0.04]. Ninety-nine patients were treated for metastatic AS; 73% had multiple metastatic sites; the lung was the most common site (36%). Chemotherapy, mainly doxorubicin- and/or paclitaxel-based regimens, were administered to 95 patients (96%). Radiotherapy was utilized in 25% cases; 16% of patients underwent curative-intent surgery. Median DSS was 10 months (95% CI: 7.9–12 months). Isolated lymph node metastasis versus hematogenic spread was the only statistically significant favorable prognostic factor identified (HR: 0.29, P = 0.01).

Conclusion

Locally recurrent AS is often treatable; complete resection can potentially prolong survival. In contrast, metastatic patients have a grave prognosis; however, patients with isolated lymphatic spread and possibly those treated with taxol-based chemotherapeutic regimens have a favorable outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Naka N, Ohsawa M, Tomita Y, et al. Prognostic factors in angiosarcoma: a multivariate analysis of 55 cases. J Surg Oncol. 1996;61:170–6.

    Article  PubMed  CAS  Google Scholar 

  2. Fayette J, Martin E, Piperno-Neumann S, et al. Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases. Ann Oncol. 2007;18:2030–6.

    Article  PubMed  CAS  Google Scholar 

  3. Deyrup AT, McKenney JK, Tighiouart M, Folpe AL, Weiss SW. Sporadic cutaneous angiosarcomas: a proposal for risk stratification based on 69 cases. Am J Surg Pathol. 2008;32:72–7.

    Article  PubMed  Google Scholar 

  4. Weiss SW, Goldblum JR. Enzinger and Weiss. Soft tissue tumors, 5th ed. St. Louis: Mosby; 2008.

    Google Scholar 

  5. Devita VT, Rosenberg SA, S H. Cancer: principles and practice of oncology, 8th ed. Philadelphia: Lippincott; 2008.

    Google Scholar 

  6. Holland JF, Frei E. Cancer medicine, 8th ed. Hamilton: BC Decker; 2009.

    Google Scholar 

  7. Fury MG, Antonescu CR, Van Zee KJ, Brennan MF, Maki RG. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J. 2005;11:241–7.

    Article  PubMed  Google Scholar 

  8. Buschmann A, Lehnhardt M, Toman N, Preiler P, Slakdeh MS, Muehlberger T. Surgical treatment of angiosarcoma of the scalp: less is more. Ann Plast Surg. 2008;61:399–403.

    Article  PubMed  CAS  Google Scholar 

  9. Mark RJ, Poen JC, Tran LM, Juillard GF. Angiosarcoma. A report of 67 patients and a review of the literature. Cancer. 1996;77:2400–6.

    Article  PubMed  CAS  Google Scholar 

  10. Maddox JC, Evans HL. Angiosarcoma of skin and soft tissue: a study of forty-four cases. Cancer. 1981;48:1907–21.

    Article  PubMed  CAS  Google Scholar 

  11. Holden CA, Spittle MF, Jones EW. Angiosarcoma of the face and scalp, prognosis and treatment. Cancer. 1987;59:1046–57.

    Article  PubMed  CAS  Google Scholar 

  12. Lydiatt WM, Shaha AR, Shah JP. Angiosarcoma of the head and neck. Am J Surg. 1994;168:451–4.

    Article  PubMed  CAS  Google Scholar 

  13. Naka N, Ohsawa M, Tomita Y, Kanno H, Uchida A, Aozasa K. Angiosarcoma in Japan. A review of 99 cases. Cancer. 1995;75:989–96.

    Article  PubMed  CAS  Google Scholar 

  14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:448–57.

    Article  Google Scholar 

  15. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163–70.

    PubMed  CAS  Google Scholar 

  16. Venables WN, Ripley BD. Modern applied statistics with Splus, 3rd ed. New York: Springer; 1999.

    Google Scholar 

  17. Espat NJ, Lewis JJ, Woodruff JM, et al. Confirmed angiosarcoma: prognostic factors and outcome in 50 prospectively followed patients. Sarcoma. 2000;4:173–7.

    PubMed  CAS  Google Scholar 

  18. Morgan MB, Swann M, Somach S, Eng W, Smoller B. Cutaneous angiosarcoma: a case series with prognostic correlation. J Am Acad Dermatol. 2004;50:867–74.

    Article  PubMed  Google Scholar 

  19. Torres MA, Ballo MT, Butler CE, et al. Management of locally recurrent soft-tissue sarcoma after prior surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 2007;67:1124–9.

    PubMed  Google Scholar 

  20. Lahat G, Tuvin D, Wei C, et al. New perspectives for staging and prognosis in soft tissue sarcoma. Ann Surg Oncol. 2008;15:2739–48.

    Article  PubMed  CAS  Google Scholar 

  21. Pawlik TM, Paulino AF, McGinn CJ, et al. Cutaneous angiosarcoma of the scalp: a multidisciplinary approach. Cancer. 2003;98:1716–26.

    Article  PubMed  Google Scholar 

  22. Fong Y, Coit DG, Woodruff JM, Brennan MF. Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg. 1993;217:72–77.

    Article  PubMed  CAS  Google Scholar 

  23. Sher T, Hennessy BT, Valero V, et al. Primary angiosarcomas of the breast. Cancer. 2007;110:173–8.

    Article  PubMed  Google Scholar 

  24. Blazer DG, 3rd, Sabel MS, Sondak VK. Is there a role for sentinel lymph node biopsy in the management of sarcoma? Surg Oncol. 2003;12:201–6.

    Article  PubMed  Google Scholar 

  25. Riad S, Griffin AM, Liberman B, et al. Lymph node metastasis in soft tissue sarcoma in an extremity. Clin Orthop Relat Res. 2004;426:129–34.

    Article  PubMed  Google Scholar 

  26. Billingsley KG, Burt ME, Jara E, et al. Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg. 1999;229:602–12.

    Article  PubMed  CAS  Google Scholar 

  27. Casson AG, Putnam JB, Natarajan G, et al. Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma. Cancer. 1992;69:662–8.

    Article  PubMed  CAS  Google Scholar 

  28. Penel N, Bui BN, Bay JO, et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol. 2008;26:5269–74.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    G. Lahat MD, A. R. Dhuka BSc, K. D. Smith MD, R. E. Pollock MD, PhD & K. K. Hunt MD

  2. The Sarcoma Research Center, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    G. Lahat MD, A. R. Dhuka BSc, S. Lahat, K. D. Smith MD, R. E. Pollock MD, PhD, A. J. Lazar MD, PhD & D. Lev MD

  3. Department of Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    V. Ravi MD

  4. Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    A. J. Lazar MD, PhD

  5. Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    D. Lev MD

Authors
  1. G. Lahat MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. R. Dhuka BSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Lahat
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. D. Smith MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. E. Pollock MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. K. Hunt MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. V. Ravi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. J. Lazar MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. D. Lev MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Lev MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lahat, G., Dhuka, A.R., Lahat, S. et al. Outcome of Locally Recurrent and Metastatic Angiosarcoma. Ann Surg Oncol 16, 2502–2509 (2009). https://doi.org/10.1245/s10434-009-0569-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-009-0569-3

Keywords

Search

Navigation